Track topics on Twitter Track topics that are important to you
BELO HORIZONTE, Brazil, Aug. 9, 2017 /PRNewswire/ -- Centro de Imagem Diagnósticos S.A. ("Alliar" or "Company") (B3: AALR3), announces today its results for the second quarter of 2017 (2Q17).
(1) Excludes "construction revenue", accounting entry referring to the investment made at RBD (PPP Bahia).
For Further Information: ir.alliar.com
INVESTOR RELATIONS TEAM Carlos Araujo | IRO
Francisco de Paula | IR Manager
Tel.: +5511 4369-1387
View original content:http://www.prnewswire.com/news-releases/alliar-annouces-2q17-results-300502428.html
SOURCE AlliarNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...